Attenuation of Hyperinsulinemia by NN414, a SUR1/Kir6.2 Selective K +-Adenosine Triphosphate Channel Opener, Improves Glucose Tolerance and Lipid Profile in Obese Zucker Rats

Metabolism: Clinical and Experimental

Volumn 53, Issue 4, 2004, Pages 441-447

  Alemzadeh, Ramin ^a   Fledelius, Christian ^b   Bodvarsdottir, Thora ^b   Sturis, Jeppe ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; FATTY ACID; HEMOGLOBIN A1C; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; LEPTIN; NN 414; POTASSIUM CHANNEL STIMULATING AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOOD INTAKE; GLUCOSE TOLERANCE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; LIPID METABOLISM; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RAT STRAIN; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 1842427224     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.10.027     Document Type: Article

References (37)

1. Smith SR: The endocrinology of obesity. Endocrinol Metab Clin North Am 25:921-942, 1996
2. Spiegelman BM, Flier JS: Adipogenesis and obesity: Rounding out the big picture. Cell 87:377-389, 1996
3. Caro JF, Dohm LG, Walter JP, et al: Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab Rev 5:665-689, 1989
4. Claycombe KJ, Jones BH, Standridge MK, et al: Insulin increases fatty acid synthase gene transcription in human adipocytes. Am J Physiol 274:R1253-R1259, 1998
5. Ewart SH, Carroll R, Severson DL: Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone. Biochemistry 327:439-442, 1997
6. Kim JB, Wright M, Yao KM, et al: Nutritional and insulin regulation of fatty acid synthase and leptin gene expression through ADD1/SREBP1. J Clin Invest 101:1-9, 1998
7. Wakil SJ, Stoops JK, Joshi VC: Fatty acid synthesis and its regulation. Annu Rev Biochem 52:579-586, 1983
8. Volpe JJ, Vagelos PR: Mechanisms and regulation of biosynthesis of saturated fat. Physiol Rev 56:339-417, 1976
9. Alemzadeh R, Slonim AE, Zdanowics MM, et al: Modification of insulin resistance by diazoxide in obese Zucker rats. Endocrinology 133:705-712, 1993
10. Alemzadeh R, Jacobs W, Pitukcheewanont P: Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 45:334-341, 1996
11. Alemzadeh R, Holshouser SJ, Massey P, et al: Chronic suppression of insulin by diazoxide alters the activities of key enzymes regulating hepatic gluconeogenesis in Zucker rats. Eur J Endocrinol 146:871-879, 2002
12. Carr RD, Gronemann S, Hansen B, et al: Diazoxide improves insulin sensitivity in Zucker obese rats. Diabetologia 41:A198, 1998 (abstr, suppl 1)
13. Standridge M, Alemzadeh R, Koontz J, et al: Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats. FASEB J 14:455-460, 2000
14. Nielsen FE, Bodvarsdottir TB, Worsaae A, et al: 6-Chloro-3-alkylamino-4H-thieno [3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic β-Cells. J Med Chem 45:4171-4187, 2002
15. ATP CO) selective for SUR1/Kir6.2 improves glucose tolerance in obese Zucker rats. Diabetologia 45:A85, 2002 (abstr 251, suppl 2)
16. Baskin DG, Figlewics DP, Woods SC, et al: Insulin in the brain. Annu Rev Physiol 49:335-347, 1987
17. Alemzadeh R, Holshouser S: Effect of diazoxide on brain capillary insulin receptor binding and food intake in hyperphagic obese Zucker rats. Endocrinology 140:3197-3202, 1999
18. Van de Werve G, Jeanrenaud B: The onset of liver glycogen synthesis in fasted-refed lean and genetically obese (fa/fa) rats. Diabetologia 30:169-174, 1987
19. Jeanrenuad B, Halimi S, Van de Werve G: Neuroendocrine disorders seen as triggers of the triad: Obesity-insulin resistance-abnormal glucose tolerance. Diabetes Metab Rev 1:261-291, 1985
20. Gruen RK, Greenwood MR: Adipose tissue lipoprotein lipase and glycerol release in fasted Zucker (fa/fa) rats. Am J Physiol 241: E76-E83, 1981
21. Standridge M, Alemzadeh R, Koontz J, et al: Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats. FASEB J 14:455-460, 2000
22. Porte D Jr: β-cells in type II diabetes mellitus. Diabetes 40:166-180, 1991
23. Leahy JL, Bonner-Weir S, Weir GC: β-cell dysfunction induced by chronic hyperglycemia. Diabetes Care 15:442-455, 1992
24. Bjorklund A, Grill V: B-cell insensitivity in vitro: Reversal by diazoxide entails more than one event in stimulus-secretion coupling. Endocrinology 123:1319-1328, 1993
25. Sako Y, Grill V: Coupling of B-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes 39:1580-1583, 1990
26. Leahy JL, Bumbalo LM, Chen C: Diazoxide causes recovery of β-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes 43:173-179, 1994
27. Aizawa T, Tagichi N, Sato Y, et al: Prophylaxis of genetically determined diabetes by diazoxide: A study in a rat model of naturally occurring obese diabetes. J Pharmacol Exp Ther 275:1194-199, 1995
28. Hiramatsu S, Hoog A, Moller C, et al: Treatment with diazoxide causes prolonged improvement of β-cell function in rat islets transplanted to a diabetic environment. Metabolism 49:657-661, 2000
29. Guldstarnd M, Grill V, Bjorklund A, et al: Improved beta cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes. Diabetes Metab 28:448-456, 2002
30. Song SH, Rhodes CJ, Veldhuis JD, et al: Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. Endocrinology 144:3399-3405, 2003
31. Cusin I, Sainsbury A, Doyle P, et al: The ob gene and insulin. Diabetes 44:1467-1470, 1995
32. Kim JB, Wright M, Yao KM, et al: Nutritional and insulin regulation of fatty acid synthase and leptin gene expression through ADD1/SREBP1. J Clin Invest 101:1-9, 1998
33. Zhao AZ, Bornfeldt KE, Beavo JA: Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest 102:869-873, 1999
34. Phillips MS, Liu QY, Hammond HA, et al: Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13:18-19, 1996
35. Lee Y, Hirose H, Zhou Y-T, et al: Increased lipogenic capacity of the islets of obese rats: A role in the pathogenesis of NIDDM. Diabetes 46:408-413, 1997
36. Zhou Y-T, Shimabukuro M, Lee Y, et al: Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: Role in the pathogenesis of lipotoxic diabetes. Diabetes 47:1904-1908, 1998
37. Klein S, Coppack SW, Mohamed-Ali V, et al: Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45: 984-987, 1996